© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Nexentis Technologies Inc. (NXTS) stock surged +2.38%, trading at $1.72 on NASDAQ, up from the previous close of $1.68. The stock opened at $1.65, fluctuating between $1.60 and $1.72 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 04, 2026 | 1.73 | 1.74 | 1.61 | 1.72 | 10.12K |
| Sep 03, 2026 | 1.68 | 1.70 | 1.62 | 1.68 | 19.7K |
| Sep 02, 2026 | 1.76 | 1.89 | 1.61 | 1.72 | 31.54K |
| Sep 01, 2026 | 1.77 | 1.77 | 1.67 | 1.76 | 14.11K |
| Aug 31, 2026 | 1.86 | 1.86 | 1.69 | 1.80 | 35.87K |
| Aug 28, 2026 | 1.89 | 2.05 | 1.75 | 1.84 | 76.11K |
| Aug 27, 2026 | 1.88 | 1.91 | 1.81 | 1.91 | 14.38K |
| Aug 26, 2026 | 1.93 | 1.93 | 1.81 | 1.88 | 12.33K |
| Aug 25, 2026 | 1.87 | 1.88 | 1.73 | 1.85 | 95.24K |
| Aug 24, 2026 | 1.84 | 1.89 | 1.75 | 1.78 | 6.59K |
| Aug 21, 2026 | 1.88 | 1.90 | 1.70 | 1.77 | 7.09K |
| Aug 20, 2026 | 1.91 | 1.91 | 1.80 | 1.80 | 43.93K |
| Aug 19, 2026 | 2.00 | 2.00 | 1.91 | 1.91 | 12.68K |
| Aug 18, 2026 | 1.95 | 1.98 | 1.85 | 1.98 | 24.81K |
| Aug 17, 2026 | 1.98 | 1.98 | 1.81 | 1.94 | 16.04K |
| Aug 14, 2026 | 1.94 | 1.97 | 1.80 | 1.91 | 13.75K |
| Aug 13, 2026 | 1.95 | 2.01 | 1.75 | 1.95 | 0 |
| Aug 12, 2026 | 1.90 | 1.97 | 1.82 | 1.84 | 9.77K |
| Aug 11, 2026 | 1.92 | 1.92 | 1.80 | 1.89 | 18.02K |
| Aug 10, 2026 | 1.97 | 1.97 | 1.86 | 1.88 | 17.24K |
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel.
| Employees | 8 |
| Beta | 1.86 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | N/A |
| Fiscal Year Ends | N/A |
| Sector | Basic Materials |
| Industry | Agricultural Inputs |